Pacific Shuanglin Bio-pharmacy Co., LTD 000403.SZ Stock
Pacific Shuanglin Bio-pharmacy Co., LTD Price Chart
Pacific Shuanglin Bio-pharmacy Co., LTD 000403.SZ Financial and Trading Overview
Contents
| Pacific Shuanglin Bio-pharmacy Co., LTD stock price | 29.33 CNY |
| Previous Close | 20.56 CNY |
| Open | 20.61 CNY |
| Bid | 20.75 CNY x N/A |
| Ask | 20.76 CNY x N/A |
| Day's Range | 20.51 - 21.12 CNY |
| 52 Week Range | 16.6 - 26.2 CNY |
| Volume | 2.78M CNY |
| Avg. Volume | 6.38M CNY |
| Market Cap | 15.39B CNY |
| Beta (5Y Monthly) | 0.509589 |
| PE Ratio (TTM) | 28.424656 |
| EPS (TTM) | 0.77 CNY |
| Forward Dividend & Yield | 0.06 (0.27%) |
| Ex-Dividend Date | July 15, 2022 |
| 1y Target Est | 29 CNY |
000403.SZ Valuation Measures
| Enterprise Value | 13.84B CNY |
| Trailing P/E | 28.424656 |
| Forward P/E | 19.761906 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.107185 |
| Price/Book (mrq) | 2.1934462 |
| Enterprise Value/Revenue | 6.392 |
| Enterprise Value/EBITDA | 21.599 |
Trading Information
Pacific Shuanglin Bio-pharmacy Co., LTD Stock Price History
| Beta (5Y Monthly) | 0.509589 |
| 52-Week Change | 7.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.2 CNY |
| 52 Week Low | 16.6 CNY |
| 50-Day Moving Average | 22.39 CNY |
| 200-Day Moving Average | 21.39 CNY |
000403.SZ Share Statistics
| Avg. Volume (3 month) | 6.38M CNY |
| Avg. Daily Volume (10-Days) | 4.14M CNY |
| Shares Outstanding | 732.64M |
| Float | 379.17M |
| Short Ratio | N/A |
| % Held by Insiders | 51.39% |
| % Held by Institutions | 10.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 0.38% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.0761 |
| Last Split Factor | 1.952679:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 24.83% |
| Operating Margin (ttm) | 24.15% |
| Gross Margin | 53.19% |
| EBITDA Margin | 29.59% |
Management Effectiveness
| Return on Assets (ttm) | 4.31% |
| Return on Equity (ttm) | 8.05% |
Income Statement
| Revenue (ttm) | 2.17B CNY |
| Revenue Per Share (ttm) | 2.96 CNY |
| Quarterly Revenue Growth (yoy) | -47.89% |
| Gross Profit (ttm) | 1.25B CNY |
| EBITDA | 640.91M CNY |
| Net Income Avi to Common (ttm) | 537.9M CNY |
| Diluted EPS (ttm) | 0.73 |
| Quarterly Earnings Growth (yoy) | -46.60% |
Balance Sheet
| Total Cash (mrq) | 1.47B CNY |
| Total Cash Per Share (mrq) | 2.01 CNY |
| Total Debt (mrq) | 415.98M CNY |
| Total Debt/Equity (mrq) | 6.01 CNY |
| Current Ratio (mrq) | 3.74 |
| Book Value Per Share (mrq) | 9.46 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 552.75M CNY |
| Levered Free Cash Flow (ttm) | -57152992 CNY |
Profile of Pacific Shuanglin Bio-pharmacy Co., LTD
| Country | China |
| State | N/A |
| City | Taiyuan |
| Address | High-Tech International Building |
| ZIP | 030006 |
| Phone | N/A |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2093 |
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.
Q&A For Pacific Shuanglin Bio-pharmacy Co., LTD Stock
What is a current 000403.SZ stock price?
Pacific Shuanglin Bio-pharmacy Co., LTD 000403.SZ stock price today per share is 29.33 CNY.
How to purchase Pacific Shuanglin Bio-pharmacy Co., LTD stock?
You can buy 000403.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pacific Shuanglin Bio-pharmacy Co., LTD?
The stock symbol or ticker of Pacific Shuanglin Bio-pharmacy Co., LTD is 000403.SZ.
Which industry does the Pacific Shuanglin Bio-pharmacy Co., LTD company belong to?
The Pacific Shuanglin Bio-pharmacy Co., LTD industry is Biotechnology.
How many shares does Pacific Shuanglin Bio-pharmacy Co., LTD have in circulation?
The max supply of Pacific Shuanglin Bio-pharmacy Co., LTD shares is 732.74M.
What is Pacific Shuanglin Bio-pharmacy Co., LTD Price to Earnings Ratio (PE Ratio)?
Pacific Shuanglin Bio-pharmacy Co., LTD PE Ratio is 38.09090800 now.
What was Pacific Shuanglin Bio-pharmacy Co., LTD earnings per share over the trailing 12 months (TTM)?
Pacific Shuanglin Bio-pharmacy Co., LTD EPS is 0.77 CNY over the trailing 12 months.
Which sector does the Pacific Shuanglin Bio-pharmacy Co., LTD company belong to?
The Pacific Shuanglin Bio-pharmacy Co., LTD sector is Healthcare.
Stocks Related By Sector
- iRay Technology Company Limited 688301.SS Stock
- China Resources Double-Crane Pharmaceutical Co.,Ltd. 600062.SS Stock
- Shanghai Allist Pharmaceuticals Co., Ltd. 688578.SS Stock
- Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. 603707.SS Stock
- Tonghua Dongbao Pharmaceutical Co., Ltd. 600867.SS Stock